Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRVI | ABT | SYK | BSX | MDT |
| Company | Maravai Lifesciences Holdings Inc Cl A | Abbott Laboratories | Stryker Corp | Boston Scientific Corp | Medtronic Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 8.96 | 106.11 | 328.65 | 72.22 | 81.07 |
| High | 9.13 | 106.64 | 331.76 | 73.08 | 81.92 |
| Low | 8.85 | 105.48 | 326.70 | 71.82 | 81.01 |
| Last | 8.97 | 105.90 | 328.45 | 72.85 | 81.69 |
| Change | +0.17 | -0.02 | +1.82 | +0.82 | +0.77 |
| % Change | +1.93% | -0.02% | +0.56% | +1.14% | +0.95% |
| Volume | 1,808,500 | 3,610,400 | 1,589,400 | 7,452,000 | 4,987,200 |
| 20-Day Average Volume | 1,663,345 | 5,221,605 | 1,460,215 | 7,346,820 | 6,081,345 |
| Previous Close | 8.80 | 105.92 | 326.63 | 72.03 | 80.92 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.06 | 107.93 | 336.64 | 69.95 | 80.72 |
| 20-Day Raw Stochastic | 91.53% | 19.83% | 25.32% | 79.71% | 55.07% |
| 20-Day Relative Strength | 62.61% | 38.27% | 39.86% | 66.71% | 48.48% |
| Weighted Alpha | -42.44 | -4.10 | +15.93 | +48.76 | -6.91 |
| Today's Opinion | 88% Buy | 24% Sell | 24% Buy | 100% Buy | 8% Sell |
| Previous Opinion | 80% Buy | 24% Sell | 24% Buy | 100% Buy | 24% Sell |
| Last Month's Opinion | 40% Buy | 24% Buy | 80% Buy | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.49% since 04/26/24 | -1.52% since 04/26/24 | -2.13% since 04/26/24 | -0.44% since 04/26/24 | +2.45% since 04/26/24 |
| Low | 7.71 on 04/29/24 | 105.15 on 05/02/24 | 320.71 on 05/01/24 | 70.97 on 05/02/24 | 79.52 on 04/29/24 |
| High | 9.13 on 05/03/24 | 108.19 on 04/29/24 | 340.42 on 04/29/24 | 73.13 on 04/29/24 | 81.92 on 05/03/24 |
| 1-Month | |||||
| %Chg | +4.18% since 04/03/24 | -4.83% since 04/03/24 | -6.42% since 04/03/24 | +6.93% since 04/03/24 | -3.89% since 04/03/24 |
| Low | 7.19 on 04/19/24 | 104.25 on 04/17/24 | 320.71 on 05/01/24 | 66.80 on 04/22/24 | 78.43 on 04/18/24 |
| High | 9.13 on 05/03/24 | 112.57 on 04/09/24 | 354.59 on 04/04/24 | 74.39 on 04/24/24 | 85.40 on 04/04/24 |
| 3-Month | |||||
| %Chg | +71.18% since 02/02/24 | -5.54% since 02/02/24 | -3.98% since 02/02/24 | +13.17% since 02/02/24 | -6.78% since 02/02/24 |
| Low | 5.05 on 02/22/24 | 104.25 on 04/17/24 | 320.71 on 05/01/24 | 64.08 on 02/06/24 | 78.43 on 04/18/24 |
| High | 9.13 on 05/03/24 | 121.64 on 03/08/24 | 361.41 on 03/11/24 | 74.39 on 04/24/24 | 88.25 on 02/07/24 |
| 6-Month | |||||
| %Chg | +30.00% since 11/03/23 | +10.50% since 11/03/23 | +18.91% since 11/03/23 | +38.68% since 11/03/23 | +12.58% since 11/03/23 |
| Low | 4.52 on 11/09/23 | 92.43 on 11/10/23 | 266.93 on 11/10/23 | 50.84 on 11/10/23 | 69.32 on 11/10/23 |
| High | 9.13 on 05/03/24 | 121.64 on 03/08/24 | 361.41 on 03/11/24 | 74.39 on 04/24/24 | 89.18 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,255,058 | 183,755,984 | 125,123,040 | 106,877,936 | 108,469,856 |
| Shares Outstanding, K | 251,400 | 1,735,184 | 380,950 | 1,467,096 | 1,327,823 |
| Annual Sales | 288,950,000 | 40,109,000,000 | 20,498,000,000 | 14,240,000,000 | 31,227,000,000 |
| Annual Net Income | -119,030,000 | 5,723,000,000 | 3,165,000,000 | 1,591,000,000 | 3,758,000,000 |
| Last Quarter Sales | 74,140,000 | 9,964,000,000 | 5,815,000,000 | 3,856,000,000 | 8,089,000,000 |
| Last Quarter Net Income | -105,960,000 | 1,225,000,000 | 1,143,000,000 | 492,000,000 | 1,322,000,000 |
| 60-Month Beta | 0.03 | 0.76 | 0.91 | 0.77 | 0.78 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 02/22/24 | 0.98 on 04/17/24 | 2.50 on 04/30/24 | 0.56 on 04/24/24 | 1.30 on 02/20/24 |
| Latest Earnings Date | 05/08/24 | 04/17/24 | 04/30/24 | 04/24/24 | 05/23/24 |
| Most Recent Dividend | N/A | 0.550 on 04/12/24 | 0.800 on 03/27/24 | N/A | 0.690 on 03/21/24 |
| Next Ex-Dividends Date | N/A | 04/12/24 | 03/27/24 | N/A | 03/21/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.13 | 29.80 | 33.66 | 15.21 |